The RAvIN Platform: A Noncarbohydrate Platform for Oligonucleotide Synthesis
Journal of the American Chemical Society · 01.04.2026 · 148 (12) · 12998-13008
DOI: 10.1021/jacs.5c21938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 18.03.2026. Verfasst von Matthew Nodwell und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cloudburst Biotech, 8999 Nelson Way, Burnaby V5A 4B5, British Columbia, Canada. Hauptthemen laut MEDLINE: Oligonucleotides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: GlycoNet, supported by the Canadian government?s Strategic Science Fund, Natural Sciences and Engineering Research Council of Canada (NSERC), Merck & Co., Inc..
Abstract (Originalsprache)
Oligonucleotide therapeutics (ONTs) are poised to become a third pillar of modern medicine. However, the practical and large-scale synthesis of ONTs and their constituent nucleoside analogue (NA) building blocks remains a major challenge. As each of the NA units must be individually designed and tailored to enhance the desired ADMET properties of the ONT, identifying economic, flexible, and scalable syntheses of these compounds is of critical importance. To date, the field has relied almost exclusively on carbohydrates as starting materials for NA synthesis. While these compounds are enantiopure and share common structural and stereochemical features with NAs, their conversion into NAs often requires challenging, low-yielding, and expensive synthetic campaigns. As a result, a large fraction of the ONT chemical space remains underexplored, and the full impact of chemical modification on the pharmacokinetic properties of the ONTs remains poorly understood. Here, we present a streamlined platform to produce NAs that will improve access to precision-edited ONTs. This approach uses achiral starting materials and relies on a dual organocatalyst, one-pot process to furnish a key class of ONT building blocks: the RAvIN (rapid access to value-added innovative nucleosides) ketones (RKs). Notably, RKs can incorporate appropriately protected natural nucleobases as well as nucleobase analogues, be made on scale in 2-4 steps with carbohydrate-like levels of enantiomeric purity, and are readily diversified to create the next-generation NAs required to improve the pharmacokinetic properties of the ONTs. Finally, we demonstrate the versatility and potential of this methodology in a totally noncarbohydrate synthesis of the all-MOE-modified 18mer ONT Nusinersen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cloudburst Biotech, 8999 Nelson Way, Burnaby V5A 4B5, British Columbia, Canada.
- Department of Chemistry, Simon Fraser University, Burnaby, V5A 1S6 British Columbia, Canada.
- Department of Chemistry, McGill University, Montreal H3A 3E8, Quebec, Canada.
- Department of Process Research and Development, Merck & Co., Inc., Rahway 07065, New Jersey, United States.
ORCID-Profile: Guillermo Caballero-García, Juan M Mesa, Steven M Silverman, Louis-Charles Campeau, Masad J Damha, Robert Britton
Förderung
- GlycoNet, supported by the Canadian government?s Strategic Science Fund
- Natural Sciences and Engineering Research Council of Canada (NSERC)
- Merck & Co., Inc.
- National Agency for Research and Innovation (Uruguay)
- Cloudburst Biotech
Zitieren
APA
Nodwell, M., Caballero-García, G., Mesa, J. M., Muilu, T., Wilson, D. M., Arora, A., Brooke, A. J., Singgh, B., Gill, M., Tran, H. M., Silverman, S. M., Campeau, L. C., Damha, M. J., & Britton, R. (2026). The RAvIN Platform: A Noncarbohydrate Platform for Oligonucleotide Synthesis. Journal of the American Chemical Society, 148(12), 12998-13008. https://doi.org/10.1021/jacs.5c21938
Vancouver
Nodwell M, Caballero-García G, Mesa JM, Muilu T, Wilson DM, Arora A, et al. The RAvIN Platform: A Noncarbohydrate Platform for Oligonucleotide Synthesis. Journal of the American Chemical Society. 2026;148(12):12998-13008. doi:10.1021/jacs.5c21938
BibTeX
@article{Nodwell2026,
author = {Nodwell, Matthew and Caballero-García, Guillermo and Mesa, Juan M and Muilu, Tommi and Wilson, Darryl M and Arora, Abhishek and Brooke, Alan J and Singgh, Bara and Gill, Mamta and Tran, Huyen M and Silverman, Steven M and Campeau, Louis-Charles and Damha, Masad J and Britton, Robert},
title = {The RAvIN Platform: A Noncarbohydrate Platform for Oligonucleotide Synthesis},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {12},
pages = {12998--13008},
doi = {10.1021/jacs.5c21938}
}
EUVIMED